WHO names Resomelagon among key dengue drug candidates
SynAct Pharma AB OMXSTO:SYNACT is mentioned in a TradingView News item stating the WHO named Resomelagon among key dengue drug candidates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.